SciBase Holding AB, a developer of augmented intelligence-based solutions for skin disorders, entered into a collaboration agreement with Schweiger Dermatology group to pilot Nevisense in their Freehold, NJ office.
Schweiger Dermatology Group is the largest dermatology practice group in the Northeastern US, with over 90 offices and more than 300 healthcare providers throughout New York, New Jersey, Pennsylvania and Connecticut. The agreement will provide Schweiger Dermatology Group’s Freehold, New Jersey practice with Nevisense, the only FDA approved test for early melanoma detection at point-of-care. Read more.
